Chronic Fatigue Syndrome
Also known as: CFS, Myalgic Encephalomyelitis, ME/CFS, Systemic Exertion Intolerance Disease
Chronic fatigue syndrome (ME/CFS) is a complex, debilitating disorder characterized by extreme fatigue that does not improve with rest and worsens with physical or mental exertion (post-exertional malaise). The exact cause remains unknown, and there is no single diagnostic test or cure. Management focuses on symptom relief and activity pacing to improve quality of life.
Last updated October 31, 2026
Understanding Chronic Fatigue Syndrome
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a long-term illness in which the body's capacity to produce and recover energy is broken. Its defining feature is not tiredness but post-exertional malaise (PEM): a crash in symptoms, often delayed by 12 to 48 hours, after physical, mental or emotional effort that would once have been trivial. About a quarter of people with ME/CFS are house- or bed-bound at some point, and most are unable to work full-time. It typically starts after an infection, which is why long COVID has brought it back into view: by current estimates roughly half of people with persistent long COVID fatigue meet ME/CFS criteria. Diagnosis rests on the 2015 Institute of Medicine criteria: six months of substantial impairment, PEM and unrefreshing sleep, plus either cognitive impairment or orthostatic intolerance.
No single abnormality explains ME/CFS, but a consistent cluster has emerged. Cardiopulmonary tests done on two consecutive days show that people with ME/CFS cannot reproduce their day-one performance, with the anaerobic threshold dropping by 10 to 20% on day two, something healthy and deconditioned people do not show. Muscle and immune cells show impaired energy production, with reduced mitochondrial output, abnormal lactate handling and a shift away from glucose use; blood tests reveal low natural killer cell function, altered cytokines and, in many, autoantibodies against adrenergic and muscarinic receptors. Autonomic dysfunction is common: on standing, heart rate climbs or blood pressure falls (postural tachycardia or orthostatic hypotension) and cerebral blood flow drops by around 25%. Brain imaging shows low-grade neuroinflammation. These findings mark a physical disease with an energy-supply problem at its center.
ME/CFS usually follows a relapsing, remitting course; roughly 5% recover fully and many improve partially, especially when PEM is avoided early. There is no approved drug for the illness itself, so conventional care manages the parts: energy management and pacing are the foundation (the 2021 NICE guideline withdrew graded exercise therapy and cognitive behavioral therapy as treatments, keeping CBT only as support for coping); low-dose amitriptyline, trazodone or melatonin for sleep; fludrocortisone, midodrine, salt and fluids, or beta-blockers for orthostatic intolerance; low-dose naltrexone (1.5 to 4.5 mg), which small studies suggest helps pain and fatigue; and treatment of migraine, irritable bowel, mast cell activation and depression when present. Rintatolimod, an immune modulator, is available in some countries but not FDA-approved. Care is best coordinated by a doctor who understands PEM.
Natural approaches are supplements with small positive trials, nothing more and nothing less. No supplement has Strong evidence in ME/CFS; the best are coenzyme Q10 and NADH, which in two randomized trials of 73 and 207 patients reduced fatigue and improved sleep over 8 to 12 weeks. L-carnitine, magnesium, high-dose B12, omega-3 and rhodiola have single trials or open-label data, several decades old and not replicated. That makes them reasonable, low-risk experiments to try one at a time for 8 to 12 weeks while keeping a symptom diary, especially where a test shows a real deficiency. They do not replace pacing, and a product that promises to 'restore mitochondria' should be weighed against the fact that the only tool shown to prevent crashes is staying inside your energy envelope.
The thing most people, including some clinicians, get wrong is to treat ME/CFS as deconditioning and prescribe pushing through. In ME/CFS exertion beyond the limit causes measurable harm, and surveys of thousands of patients consistently report that graded exercise made more people worse than better. Pacing means spending less than you have: planning rest before activity, breaking tasks into pieces, using a heart-rate monitor to stay below the anaerobic threshold (often around 100 to 110 beats per minute, or roughly 55% of age-predicted maximum), and stopping before symptoms appear rather than after. It feels like giving up; it is the opposite, because it is the one approach that reliably reduces crashes and gives the body room to recover.
At a Glance
- Common symptoms
- Severe, persistent fatigue lasting at least 6 months, Post-exertional malaise (symptom worsening after physical or mental effort), Unrefreshing sleep despite adequate hours
- Main treatments
- Activity pacing and energy management (staying within energy envelope), Cognitive behavioral therapy adapted for ME/CFS, Medications for specific symptoms (sleep aids, pain relievers, low-dose naltrexone)
- Category
- Neurological · Affects an estimated 836,000 to 2.5 million Americans
- See a doctor if
- Persistent, unexplained fatigue significantly limits your daily activities
Symptoms
Causes
- Exact cause unknown; likely multifactorial
- Viral infections may trigger onset (EBV, HHV-6, enteroviruses)
- Immune system dysfunction
- Hormonal imbalances (hypothalamic-pituitary-adrenal axis)
- Autonomic nervous system dysregulation
Risk Factors
- Female sex (2-4 times more common in women)
- Age between 40 and 60 (peak onset)
- History of allergies or autoimmune conditions
- High levels of stress or emotional trauma
- Genetic predisposition
Diagnosis
- Diagnosis of exclusion—ruling out other medical and psychiatric conditions
- Criteria require fatigue for 6+ months with substantial reduction in activity
- Must include post-exertional malaise and unrefreshing sleep
- Blood tests, imaging, and sleep studies to exclude other causes
Treatment
- Activity pacing and energy management (staying within energy envelope)
- Cognitive behavioral therapy adapted for ME/CFS
- Medications for specific symptoms (sleep aids, pain relievers, low-dose naltrexone)
- Graded exercise therapy (controversial; gentle approaches only)
- Treatment of co-occurring conditions (depression, sleep disorders)
Natural remedies for chronic fatigue syndrome: what the evidence says
Ranked by the strength of human evidence for chronic fatigue syndrome specifically. These sit alongside medical care, not in place of it.
Coenzyme Q10
Moderate evidenceCoenzyme Q10 shuttles electrons in the mitochondrial chain, and its blood and cell levels are lower in ME/CFS than in controls. In a randomized placebo-controlled trial of 73 Spanish patients, 200 mg CoQ10 plus 20 mg NADH daily for 8 weeks cut fatigue scores and raised cellular ATP and antioxidant markers; a follow-up of 207 patients over 12 weeks found less cognitive fatigue and better sleep quality than placebo, though overall quality of life did not separate. Effects were modest, and the trials used the combination, so CoQ10 alone is less well tested.
- Studied dose
- 200 mg ubiquinone (or 100 to 200 mg ubiquinol) daily with a fat-containing meal, combined with 20 mg NADH in the trials, for at least 8 weeks.
- Cautions
- Reduces the effect of warfarin (lowers INR) and can modestly lower blood pressure and blood sugar, so adjust diabetes or antihypertensive drugs with monitoring. Mild insomnia if taken late; take it with breakfast. Safe with low-dose naltrexone and antidepressants.
NAD+ (as NADH)
Moderate evidenceNADH is the reduced form of NAD+, the coenzyme that carries energy from food to ATP production. In a 4-week crossover trial of 26 ME/CFS patients, 10 mg oral NADH produced a meaningful improvement in 31% versus 8% on placebo; a 2004 trial found it compared well with conventional management over the first months, and the two larger Spanish trials combining 20 mg NADH with CoQ10 reduced fatigue over 8 to 12 weeks. These are small studies with soft endpoints, so the evidence is Moderate at best, but NADH is the most consistently tested energy cofactor in this illness.
- Studied dose
- 10 to 20 mg stabilized oral NADH on an empty stomach each morning; NAD+ precursors such as NMN and nicotinamide riboside have not been tested in ME/CFS.
- Cautions
- Can cause jitteriness, insomnia or loss of appetite in the first days; take it in the morning. No known interactions with common ME/CFS medications. Expensive, so set a 12-week trial and stop if nothing changes.
L-carnitine
Preliminary evidenceCarnitine carries fatty acids into mitochondria, and several studies have found low serum or muscle acylcarnitine in ME/CFS. In an 8-week comparison of 30 patients, 3 g L-carnitine daily improved 12 of 18 clinical measures while the comparison drug amantadine was poorly tolerated; a 24-week open-label study of 90 patients found 2 g acetyl-L-carnitine improved mental fatigue and 2 g propionyl-L-carnitine improved general fatigue in about 60% of patients, but the combination did worse. With no placebo-controlled trial, the evidence is Preliminary.
- Studied dose
- 2 g acetyl-L-carnitine or 2 to 3 g L-carnitine daily in divided doses with meals for 8 to 24 weeks.
- Cautions
- May increase warfarin effect; rare seizures in people with seizure disorders; fishy odor and gastrointestinal upset. Doses above 3 g a day raise TMAO levels. Avoid in untreated hypothyroidism, since carnitine blunts thyroid hormone action.
Magnesium glycinate
Preliminary evidenceMagnesium is required at every step of ATP production, and a 1991 Lancet study found lower red cell magnesium in 20 ME/CFS patients than in controls; in its randomized arm, 32 patients given weekly intramuscular magnesium sulfate for 6 weeks reported better energy, mood and less pain than placebo (12 of 15 improved versus 3 of 17). Two later studies failed to find low magnesium in ME/CFS, and no oral trial exists, so the evidence is a single old trial. Glycinate is chosen for tolerability and because glycine itself aids sleep.
- Studied dose
- 200 to 400 mg elemental magnesium as glycinate daily, in the evening or divided, for 6 to 12 weeks.
- Cautions
- Reduce or avoid with significant kidney disease, where magnesium accumulates. Separate by 2 hours from quinolone and tetracycline antibiotics and bisphosphonates. Loose stool signals too much; glycinate causes less than citrate or oxide.
Vitamin B12
Preliminary evidenceHigh-dose B12 has been used in ME/CFS for decades on the theory that it supports methylation and energy metabolism in the nervous system. The best data are observational: in a Swedish series of 38 patients on frequent B12 injections (mostly methylcobalamin, 1 to 5 mg every few days) plus folic acid, those on the highest doses and longest treatment reported the best response, while opioids and other drugs blunted it. There is no placebo-controlled trial in ME/CFS. Measured B12 or folate deficiency, which mimics the fatigue and brain fog of the illness, is the clear indication to treat.
- Studied dose
- 1,000 mcg methylcobalamin or hydroxocobalamin daily by mouth, or injections where deficiency or malabsorption is confirmed, with 400 to 800 mcg folate.
- Cautions
- Very safe; rare acne or injection-site reactions. Metformin, proton pump inhibitors and nitrous oxide lower B12. Folic acid above 1 mg a day can mask B12 deficiency, so test before starting both.
Omega-3 fatty acids
Preliminary evidenceEssential fatty acid levels are reduced in some ME/CFS cohorts, and omega-3s lower the inflammatory cytokines seen in the illness. In a 1990 trial of 63 patients with post-viral fatigue, 3 months of a combined evening primrose and fish oil product improved overall condition in 85% versus 17% on placebo, but a careful 1999 replication in 50 patients found no benefit over placebo. The evidence is Preliminary and contradictory, with the general cardiovascular and mood benefits of omega-3 as the main reason to use it.
- Studied dose
- 1 to 2 g combined EPA and DHA daily with food; the positive trial used 8 capsules a day of a mixed evening primrose and fish oil product.
- Cautions
- Increases bleeding with warfarin, aspirin and other antiplatelets; stop 1 to 2 weeks before surgery. High doses (4 g or more) have been linked to atrial fibrillation. Fish burps and loose stool are the common complaints.
Rhodiola rosea
Preliminary evidenceRhodiola is an adaptogen that has been tested in stress-related fatigue rather than ME/CFS itself. In a 28-day randomized trial of 60 people with burnout-type fatigue, 576 mg of a standardized extract reduced fatigue scores and the morning cortisol response versus placebo; an 8-week open-label study of 100 people with prolonged or chronic fatigue found steady improvement on 400 mg a day, with most gain in the first week. None of these participants met ME/CFS criteria, so the tier is Preliminary, and its mild stimulant quality can tempt people to overdo activity and crash.
- Studied dose
- 200 to 400 mg standardized extract (3% rosavins, 1% salidroside) in the morning for 4 to 8 weeks; avoid afternoon doses.
- Cautions
- Can cause agitation, insomnia and dry mouth; use cautiously with antidepressants (serotonergic activity) and in bipolar disorder. May lower blood pressure and blood sugar. Not studied in pregnancy. Do not use it to push past your energy limit.
What matters day to day
- Pace with a heart-rate monitor: keep activity below your estimated anaerobic threshold (about 55% of 220 minus your age, often 100 to 110 bpm) and rest before, not after, exertion; this is the strategy patients most consistently report reduces crash frequency.
- Keep a 2-week activity and symptom diary to find your energy envelope, then plan to use about 70 to 80% of it; PEM is usually delayed 12 to 48 hours, so today's crash often traces to the day before yesterday.
- Treat orthostatic intolerance: 2 to 3 liters of fluid and 3 to 5 g of extra salt daily (unless hypertensive), compression garments to the waist, and raising the head of the bed reduce the dizziness and brain fog that come from a 25% drop in brain blood flow on standing.
- Anchor sleep with a fixed wake time, no screens for an hour before bed and the bedroom cool and dark; unrefreshing sleep worsens every other symptom, and a sleep study is worth asking for, since sleep apnea coexists in a meaningful minority.
- Reduce cognitive load the way you reduce physical load: mental effort triggers PEM just as reliably, so batch calls and decisions, use written lists and noise-cancelling headphones, and schedule screen-free rest periods.
- Avoid alcohol and limit caffeine: most people with ME/CFS report new alcohol intolerance, and caffeine borrows energy you then pay back as a crash.
Prevention
- No proven prevention methods exist
- Prompt treatment of infections and stress management may reduce risk
- Adequate rest during and after illness
When to See a Doctor
- Persistent, unexplained fatigue significantly limits your daily activities
- You experience post-exertional malaise after minor activities
- Cognitive difficulties and unrefreshing sleep are ongoing
- You need help managing symptoms that don't improve with rest
Frequently Asked Questions
References
- Institute of Medicine Committee on the Diagnostic Criteria for ME/CFS. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. National Academies Press (2015)
- National Institute for Health and Care Excellence. Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management (NICE guideline NG206) (2021)
- Centers for Disease Control and Prevention. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (2024)View source
- Castro-Marrero J, Cordero MD, Segundo MJ, et al.. Does oral coenzyme Q10 plus NADH supplementation improve fatigue and biochemical parameters in chronic fatigue syndrome?. Antioxidants & Redox Signaling (2015)
- Castro-Marrero J, Segundo MJ, Lacasa M, et al.. Effect of dietary coenzyme Q10 plus NADH supplementation on fatigue perception and health-related quality of life in individuals with myalgic encephalomyelitis/chronic fatigue syndrome: a prospective, randomized, double-blind, placebo-controlled trial. Nutrients (2021)
- Forsyth LM, Preuss HG, MacDowell AL, et al.. Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome. Annals of Allergy, Asthma & Immunology (1999)
- Plioplys AV, Plioplys S. Amantadine and L-carnitine treatment of chronic fatigue syndrome. Neuropsychobiology (1997)
- Cox IM, Campbell MJ, Dowson D. Red blood cell magnesium and chronic fatigue syndrome. Lancet (1991)
- Larun L, Brurberg KG, Odgaard-Jensen J, Price JR. Exercise therapy for chronic fatigue syndrome. Cochrane Database of Systematic Reviews (2019)
- Polo O, Pesonen P, Tuominen E. Low-dose naltrexone in the treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Fatigue: Biomedicine, Health & Behavior (2019)
Related Conditions
Evidence-graded guides
Lab tests that relate to chronic fatigue syndrome
Related from the Supplement Library
CoQ10 (Ubiquinone)
StrongCompound · Mitochondrial energy production (ATP)
Vitamin B12
StrongVitamin · Nervous system health and myelin formation
Magnesium Glycinate
StrongMineral · Improves sleep quality and onset
Rhodiola Rosea
ModerateAdaptogen · Reduces fatigue and burnout
Iron
StrongMineral · Oxygen transport via hemoglobin
These supplements have been studied in relation to Chronic Fatigue Syndrome. Always consult your healthcare provider before starting any supplement, especially if you take medications.
Related Reading
Have questions about Chronic Fatigue Syndrome?
Ask Mother Nature AI for personalized, evidence-based guidance.
Medical Disclaimer: This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.
Content reviewed against peer-reviewed medical literature and clinical guidelines. Read our editorial standards.